Here today on ENMEDIA Explores we’re hosting diagnostic company Veracyte’s former CSO and CMO Dr. Giulia Kennedy and Dr. Bernard Peperstraete, the CEO of AcuamarkDx, an early detection and monitoring company. They say cracking early cancer detection could take liquid biopsy from an $8B market to an $80B market. And they may have the solution for how to do it.

Learn more at: www.AcuamarkDx.com

Submit story ideas: www.ENMEDIA.network

Thank you to our talented ENMEDIA Explores team: Publisher: Virginia Amann / Producer: Sherif Youssef / Host: Jeremy Tunis, Esq. / Visual Designers: Jen Fenton and Taylor Thomas / Podcast Coordinator: Yona Berzon

Disclaimer: The views, information, or opinions expressed in the ENMEDIA Explores podcast are solely those of the individuals involved and do not necessarily represent those of ENMEDIA and its employees. This podcast is for informational purposes only and should not be taken as professional advice. ENMEDIA is not responsible for any actions taken based on the content of this podcast. All rights reserved, ENMEDIA, an ENTENTE Network company.